Search Orphan Drug Designations and Approvals
-
Generic Name: | 8-bromo-2-(1-methylpiperidin-4-yl) amino)-4-(4-phenoxyphenyl) amino) pyrido[4,3-d] pyrimidin-5(6H)-one hydrochloride |
---|---|
Date Designated: | 11/20/2018 |
Orphan Designation: | Treatment of Acute Myeloid Leukemia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Oscotec Inc. Korea Bio-Park Bldg A, 9th Floor 700 Dawwangpangyo-ro, Bundang-gu Seongnam-si, Gyeonggi-do South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-